Department of Pharmacology, Toxicology, and Biochemical Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Toxicol Sci. 2012 Jul;128(1):137-46. doi: 10.1093/toxsci/kfs154. Epub 2012 Apr 26.
Arsenic is known to be a human carcinogen as well as one of the most effective drugs for treatment of patients with acute promyelocytic leukemia. The intermediate metabolites of arsenic, monomethylarsonous acid (MMA(III)) and dimethylarsinous acid (DMA(III)), are formed by methylation reactions, and they are more reactive and toxic than the inorganic precursor arsenite (iAs(III)); however, the detailed mechanism of toxicity is poorly understood. Here, we studied the effects of three arsenic compounds (i.e., iAs(III), MMA(III), and DMA(III)) on mitochondrial permeability transition pore (mPTP) and release of apoptotic cytochrome c (Cyt c) after incubating with rat liver mitochondria. Inorganic iAs(III) had no effect on mitochondrial swelling even at higher concentrations ranging up to 100 μM, but swelling was significantly induced in the presence of Ca(2+). Additionally, mitochondrial swelling was strongly induced by exposure to the methylated forms of MMA(III) and DMA(III) in a dose-dependent manner in the absence of Ca(2+), suggesting that the methylated forms may have potent effects on cellular mitochondria. Although mitochondrial swelling was completely inhibited in the presence of cyclosporin-A (an inhibitor of mitochondrial permeability transition) or ruthenium red (an inhibitor of Ca(2+) uniporter) following exposure to methylated arsenicals, the release of apoptotic Cyt c from mitochondria was not inhibited, indicating that release of Cyt c is probably not dependent on mPTP opening. In addition, inhibitors of Bax (e.g., Bax-inhibiting peptide) did not reduce the release of Cyt c from the mitochondria by formation of Bax-voltage-dependent anion channel (VDAC) complex, whereas the recombinant Bcl-x(L )proteins significantly reduced the release of Cyt c after exposure to DMA(III), suggesting that dimethylated DMA(III) directly interacted with the VDAC in mitochondria and caused the release of Cyt c from mitochondria.
砷被认为是一种人类致癌物质,也是治疗急性早幼粒细胞白血病患者的最有效药物之一。砷的中间代谢物,一甲基砷酸(MMA(III))和二甲基砷酸(DMA(III)),是通过甲基化反应形成的,它们比无机前体亚砷酸盐(iAs(III))更具反应性和毒性;然而,其毒性的详细机制尚不清楚。在这里,我们研究了三种砷化合物(即 iAs(III)、MMA(III) 和 DMA(III))在孵育大鼠肝线粒体后对线粒体通透性转换孔(mPTP)和凋亡细胞色素 c(Cyt c)释放的影响。无机 iAs(III) 即使在高达 100 μM 的较高浓度下也没有引起线粒体肿胀,但在存在 Ca(2+) 的情况下则会明显诱导肿胀。此外,在不存在 Ca(2+) 的情况下,MMA(III) 和 DMA(III) 的甲基化形式以剂量依赖的方式强烈诱导线粒体肿胀,表明甲基化形式可能对细胞线粒体具有很强的作用。尽管在用甲基化砷处理后,用环孢菌素 A(线粒体通透性转换的抑制剂)或钌红(Ca(2+) 单向转运抑制剂)存在时,线粒体肿胀完全被抑制,但凋亡 Cyt c 从线粒体中的释放没有被抑制,表明 Cyt c 的释放可能不依赖于 mPTP 的开放。此外,Bax 抑制剂(例如,Bax 抑制肽)不能减少 Bax-电压依赖性阴离子通道(VDAC)复合物形成引起的 Cyt c 从线粒体中的释放,而重组 Bcl-x(L) 蛋白在暴露于 DMA(III) 后显著减少 Cyt c 的释放,表明二甲基化 DMA(III) 直接与线粒体中的 VDAC 相互作用并导致 Cyt c 从线粒体中释放。